Back to Trades
Tsai John
DirectorCIK 0001960467
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025
Tsai John, Director, accounts for 1 disclosed filing worth $1.2M, all concentrated in Blueprint Medicines Corp (BPMC), active 2025. Data is sourced from official SEC Form 3, 4, and 5 filings.